Having trouble accessing articles? Reset your cache.

Velcade bortezomib: Phase III data

Researchers from the University Hospital of Salamanca reported data from an open-label, Spanish Phase III trial in 260 treatment-naïve patients ages 65 and older showing that induction therapy with a less-intensive Velcade-based regimen, followed

Read the full 345 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE